New Bisphosphonates Inhibit Breast Cancer Growth
Author Information
Author(s): Abdelkarim Mohamed, Guenin Erwann, Sainte-Catherine Odile, Vintonenko Nadejda, Peyri Nicole, Perret Gerard Yves, Crepin Michel, Khatib Abdel-Majid, Lecouvey Marc, Di Benedetto Mélanie
Primary Institution: Université Paris 13, CNRS FRE CSPBAT, Laboratoire de Chimie Structurale Biomoléculaire, Laboratoire de pharmacologie, Université Paris 13, UFR SMBH, Bobigny, France
Hypothesis
Can new symmetrically esterified bisphosphonates effectively inhibit breast cancer growth and metastasis?
Conclusion
The study suggests that a new class of esterified bisphosphonates can inhibit breast cancer growth and metastasis without toxic side effects.
Supporting Evidence
- The new bisphosphonates were more effective in inhibiting tumor cell proliferation compared to previous compounds.
- Both BP7033Br and BP7033Br ALK significantly reduced tumor growth in mouse models.
- BP7033Br ALK showed a greater ability to inhibit metastasis compared to BP7033Br.
Takeaway
Scientists created a new medicine that helps stop breast cancer from growing and spreading, and it doesn't make people sick.
Methodology
The study synthesized new bisphosphonates and tested their effects on various breast cancer cell lines and in mouse models.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website